Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 125 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1241 9.7 months NSCLC 5 Biologic therapy
Chemotherapy
Yale Cancer Center and Smilow Cancer Hospital United States 4/2012
Treatment Details: Patients: This phase II study involved non-small cell lung cancer patients who had not been previously treated with chemotherapy and were divided into separate treatment groups. Group A co
 
1242 9.7 months Urothelial tract carcinoma 5 Biologic therapy
Chemotherapy
Fox Chase Cancer Center United States 10/2012
Treatment Details: Patients: This phase 2 study involved previously treated advanced urothelial tract carcinoma patients who were divided into two separated treatment groups. Group A consisted of 11 patients
 
1243 9.7 months Malignant mesothelioma 4 Biologic therapy
University of California United States 10/2010
Treatment Details: Patients: This phase II study involved 51 malignant mesothelioma patients, 70% of whom were male. The median patient age was 69 years. Treatment: Patients were treated with the biolog
 
1244 9.7 months Hepatocellular carcinoma 5 Biologic therapy
National Cancer Centre Singapore Singapore 7/2012
Treatment Details: Patients: This phase 2 study involved 44 patients with unresectable or metastatic hepatocellular carcinoma. The median patient age was 62.5 years and 82% were male. Treatment: Patients
 
1245 9.7 months Recurrent ovarian cancer 4 Chemotherapy
University Hospitals Leuven and Leuven Cancer Institute Belgium 10/2012
Treatment Details: Patients: This study involved 63 recurrent ovarian cancer patients with a median age of 61 years. Treatment: Patients were treated with the chemotherapy agents paclitaxel and carboplati
 
1246 9.7 months Metastatic breast cancer 4 Chemotherapy
Oncology Institute Italy 2/2003
Treatment Details: Patients: This Phase I/II study involved 63 women with metastatic breast cancer. All patients had been previously treated with chemotherapy. Treatment: Treatment consisted of the admin
 
1247 9.7 months Newly diagnosed GBM 4 Chemotherapy
Radiation
Fox Chase Cancer Center, United States 9/2001
Treatment Details: Patients: This Phase II study involved 62 patients with supratentorial glioblastoma multiforme. One patient was removed after refusing protocol treatment. Treatment: Treatment consisted
 
1248 9.7 months Newly diagnosed GBM 4 Chemotherapy
Radiation
University of California San Francisco United States 1/2001
Treatment Details: Patients: This study included 231 patients with newly diagnosed glioblastoma multiforme. (Six patients were later determined to have a gliosarcoma.) The patients were divided into four tre
 
1249 9.7 months Newly diagnosed GBM 4 Chemotherapy
Radiation
London Regional Cancer Center Canada 2/2001
Treatment Details: Patients: This Phase I trial included 47 patients with glioblastoma multiforme. Treatment: The treatment consisted of a chemotherapy drug, topotecan (hycamtin) plus cranial radiation.
 
1250 9.7 months metastatic melanoma 4 Chemotherapy
University of Tubingen Germany 10/2005
Treatment Details: Patients: This Phase III study involved a total of 271 patients with metastatic melanoma who were divided into two groups: Group A of 137 patients and Group B of 134 patients. For Group B t
 
Page 125 of 187  | Previous Page  | Next Page